Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
1.160
+0.020 (1.75%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Enzo Biochem Cash Flow Statement
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '24 Apr 30, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 | 2018 - 2014 |
| Net Income | 44.73 | 20.29 | -18.26 | 7.88 | -28.52 | 2.49 | Upgrade
|
| Depreciation & Amortization | 1.48 | 2.68 | 2.83 | 2.65 | 2.78 | 3.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.2 | 0.2 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 1.28 | 0.08 | - | - | Upgrade
|
| Stock-Based Compensation | 2.91 | 3.15 | 2.34 | 1.64 | 1.77 | 1.79 | Upgrade
|
| Other Operating Activities | 3.17 | 0.78 | 2.06 | -7.09 | -1.17 | 0.49 | Upgrade
|
| Change in Accounts Receivable | 5.65 | 5.03 | -1.3 | -1.11 | 1.62 | 2.4 | Upgrade
|
| Change in Inventory | 0.21 | -0.33 | -2.74 | -4.94 | 0.09 | -0.57 | Upgrade
|
| Change in Accounts Payable | -11.62 | 1.16 | 0.39 | -0.4 | 1.21 | -2.51 | Upgrade
|
| Change in Other Net Operating Assets | -6.29 | 12.7 | -3.19 | 1.67 | 5.04 | -2.33 | Upgrade
|
| Operating Cash Flow | -42.21 | -36.98 | -16.59 | 0.39 | -17.18 | 4.81 | Upgrade
|
| Capital Expenditures | -1 | -2.76 | -3.47 | -4.44 | -2.17 | -8.13 | Upgrade
|
| Investment in Securities | - | - | 28.7 | -30.06 | - | - | Upgrade
|
| Other Investing Activities | 101.74 | 101.74 | - | - | - | - | Upgrade
|
| Investing Cash Flow | 100.75 | 98.98 | 25.22 | -34.5 | -2.17 | -8.13 | Upgrade
|
| Short-Term Debt Issued | - | 16.85 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 7 | - | - | 7.41 | 4.5 | Upgrade
|
| Total Debt Issued | 16.28 | 23.85 | - | - | 7.41 | 4.5 | Upgrade
|
| Short-Term Debt Repaid | - | -16.85 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -8.14 | -0.27 | -0.34 | -0.41 | -0.4 | Upgrade
|
| Total Debt Repaid | -20.63 | -24.98 | -0.27 | -0.34 | -0.41 | -0.4 | Upgrade
|
| Net Debt Issued (Repaid) | -4.35 | -1.14 | -0.27 | -0.34 | 7 | 4.1 | Upgrade
|
| Issuance of Common Stock | 0.39 | 0.4 | 0.03 | 0.1 | - | 0.17 | Upgrade
|
| Other Financing Activities | -0.39 | -0.39 | - | - | - | -0.07 | Upgrade
|
| Financing Cash Flow | -4.82 | -1.13 | -0.24 | -0.24 | 7 | 4.19 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.19 | -0.11 | -0.06 | 0.01 | 0.07 | -0.02 | Upgrade
|
| Net Cash Flow | 53.52 | 60.77 | 8.33 | -34.34 | -12.28 | 0.86 | Upgrade
|
| Free Cash Flow | -43.2 | -39.74 | -20.06 | -4.05 | -19.35 | -3.32 | Upgrade
|
| Free Cash Flow Margin | -129.57% | -127.93% | -61.46% | -3.44% | -25.45% | -4.09% | Upgrade
|
| Free Cash Flow Per Share | -0.86 | -0.81 | -0.41 | -0.08 | -0.41 | -0.07 | Upgrade
|
| Cash Interest Paid | 1.32 | 1.25 | 0.23 | 0.24 | 0.27 | 0.14 | Upgrade
|
| Cash Income Tax Paid | 0.04 | 0.02 | 0.13 | 0.31 | 0.09 | 0.09 | Upgrade
|
| Levered Free Cash Flow | -11.13 | 16.57 | -13.93 | -4.8 | -10.48 | -23.01 | Upgrade
|
| Unlevered Free Cash Flow | -10.43 | 17.27 | -13.93 | -4.8 | -10.48 | -23.01 | Upgrade
|
| Change in Net Working Capital | 3.25 | -29.66 | 4.67 | 5.09 | -6.13 | 2.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.